Cargando…

Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea

Morphea/localized scleroderma (LoS) represents an inflammatory-sclerotic skin disease, the pathogenesis of which is not fully understood. Given the important role of IL-1 family cytokines in the development and therapy of inflammatory diseases, including systemic sclerosis, we analyzed the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szczepanik-Kułak, Paulina, Michalska-Jakubus, Małgorzata, Kowal, Małgorzata, Krasowska, Dorota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655385/ https://www.ncbi.nlm.nih.gov/pubmed/36362603 http://dx.doi.org/10.3390/jcm11216375

Ejemplares similares

Laser Therapy for the Treatment of Morphea: A Systematic Review of Literature
por: Szczepanik-Kułak, Paulina, et al.
Publicado: (2021)

Evaluation of serum concentrations of the selected cytokines in patients with localized scleroderma
por: Budzyńska-Włodarczyk, Jolanta, et al.
Publicado: (2016)

Usefulness of Dermoscopy in Localized Scleroderma (LoS, Morphea) Diagnosis and Assessment-Monocentric Cross-Sectional Study
por: Szczepanik-Kułak, Paulina, et al.
Publicado: (2022)

Clinical associations of serum leptin and leptin/adiponectin ratio in systemic sclerosis
por: Michalska-Jakubus, Małgorzata, et al.
Publicado: (2018)

A novel miRNA-4484 is up-regulated on microarray and associated with increased MMP-21 expression in serum of systemic sclerosis patients
por: Rusek, Marta, et al.
Publicado: (2019)

Anti-endothelial cell antibodies do not correlate with disease activity in systemic sclerosis
por: Michalska-Jakubus, Małgorzata, et al.
Publicado: (2018)

Visfatin and chemerin levels correspond with inflammation and might reflect the bridge between metabolism, inflammation and fibrosis in patients with systemic sclerosis
por: Sawicka, Karolina, et al.
Publicado: (2019)

Anti-endothelial cell antibodies are associated with apoptotic endothelial microparticles, endothelial sloughing and decrease in angiogenic progenitors in systemic sclerosis
por: Michalska-Jakubus, Małgorzata M., et al.
Publicado: (2019)

NOTCH3 T6746C and TP53 P72R Polymorphisms Are Associated with the Susceptibility to Diffuse Cutaneous Systemic Sclerosis
por: Zmorzyński, Szymon, et al.
Publicado: (2020)

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis
por: Kowal-Bielecka, Otylia, et al.
Publicado: (2013)

Photodynamic Therapy in the Treatment of Vulvar Lichen Sclerosus: A Systematic Review of the Literature
por: Gerkowicz, Agnieszka, et al.
Publicado: (2021)

Localized Blistering Eruption of the Face and Neck – A Case Study and Differential Considerations
por: Michalska-Jakubus, Małgorzata, et al.
Publicado: (2022)

Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients
por: Michalak-Stoma, Anna, et al.
Publicado: (2021)

IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity
por: Michalak-Stoma, Anna, et al.
Publicado: (2020)

Occupational exposure as a presumable cause of subcutaneous sarcoidosis in a tannery worker – case report and review of the literature
por: Michalska-Jakubus, Małgorzata M., et al.
Publicado: (2018)

Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature
por: Polkowska-Pruszyńska, Beata, et al.
Publicado: (2018)

Mucous membrane pemphigoid as a cause of acute dysphagia – an endoscopic study
por: Sawicka, Karolina, et al.
Publicado: (2015)

Bullous pyoderma gangrenosum associated with pancytopenia of unknown origin
por: Wolska, Katarzyna, et al.
Publicado: (2014)

Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis
por: Michalak-Stoma, Anna, et al.
Publicado: (2022)

Serum Levels of Selected Th17 and Th22 Cytokines in Psoriatic Patients
por: Michalak-Stoma, Anna, et al.
Publicado: (2013)

Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis
por: Bartosińska, Joanna, et al.
Publicado: (2022)

Selected miRNA and Psoriasis—Cardiovascular Disease (CVD)—Overweight/Obesity Network—A Pilot Study
por: Michalak-Stoma, Anna, et al.
Publicado: (2023)

Controversy around the morphea
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2021)

Analysis of circulating soluble programmed death 1 (PD-1), neuropilin 1 (NRP-1) and human leukocyte antigen-G (HLA-G) in psoriatic patients
por: Bartosińska, Joanna, et al.
Publicado: (2018)

The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis
por: Adamczyk, Michał, et al.
Publicado: (2023)

Analysis of serum chemerin concentrations in psoriatic patients in relation to metabolic abnormalities
por: Chyl-Surdacka, Katarzyna M., et al.
Publicado: (2019)

Morphea – selected local treatment methods and their effectiveness
por: Narbutt, Joanna, et al.
Publicado: (2017)

Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients
por: Bartosińska, Joanna, et al.
Publicado: (2021)

Dermoscopy of Morphea
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2019)

Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkers
por: Wolska-Gawron, Katarzyna, et al.
Publicado: (2020)

Morphea on the breast and pregnancy
por: Benchat, Loubna, et al.
Publicado: (2013)

Cryolipolysis-induced morphea
por: Ladha, Malika, et al.
Publicado: (2019)

Morphea and antithyroid antibodies
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2018)

Autoantibodies in Morphea: An Update
por: Khatri, Sangita, et al.
Publicado: (2019)

Upcoming treatments for morphea
por: Wenzel, Dan, et al.
Publicado: (2021)

Morphea: The 2023 update
por: Papara, Cristian, et al.
Publicado: (2023)

Decreased blood CD4+PD-1+ and CD8+PD-1+ T cells in psoriatic patients with and without arthritis
por: Bartosińska, Joanna, et al.
Publicado: (2018)

Suppressed Programmed Death 1 Expression on CD4(+) and CD8(+) T Cells in Psoriatic Patients
por: Bartosińska, Joanna, et al.
Publicado: (2017)

Development of keloidal morphea after treatment with cyclosporine in a case of recalcitrant generalized morphea
por: Dadkhahfar, Sahar, et al.
Publicado: (2020)

Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC)
por: Gudbrandsdottir, Gigja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bg6akckfq2sgko3rrh81t87vl5